Ahrn B, Masmiquel L, Kumar H, Sargin M, Karsbl JD, Jacobsen SH, Chow F
Knowing your options matters because different sites suit different body types, comfort preferences, and daily routines
Coverage for Wegovy for weight loss may be more limited
Read More: VA Study: Ozempic, Other GLP-1 Drugs May Fight Addiction Across Every Major Substance A larger VA medication use evaluation across 37 VA medical centers found that semaglutide was among the most frequently prescribed weight management medications in the VA system and that veterans who combined medication with the VAs Move! behavioral weight management program achieved higher rates of clinically significant weight loss than those on medication alone
The FDA label states that providers should consider discontinuing treatment if patients do not achieve at least 5% weight loss after 12 weeks at the maintenance dose, as continued use is unlikely to provide meaningful clinical benefit